AROVELLA THERAPEUTICS LIMITED

7.14%

10.5¢

Market Cap $124.7M

Healthcare Biotechnology

Arovella Therapeutics Limited is a biotechnology company. The Company is focused on... Arovella Therapeutics Limited is a biotechnology company. The Company is focused on developing its invariant natural killer T (iNKT) cell therapy platform from Imperial College London to treat blood cancers and solid tumors. The Company's lead product is ALA-101. ALA-101 is being developed as an allogeneic cell therapy, which means it can be given from a healthy donor to a patient. ALA-101 is a next-generation CAR-iNKT cell therapy that targets CD19+ B cell lymphomas and leukemias. ALA-101 consists of CAR19-iNKT cells that have been modified to produce a Chimeric Antigen Receptor (CAR) that targets CD19. CD19 is an antigen found on the surface of numerous cancer types. The Company is also engaged in expanding solid tumor treatment through its CLDN18.2-targeting technology licensed from Sparx Group. Its iNKT cells also contain an invariant T cell receptor (iTCR) that targets alpha-galactosylceramide (a-GalCer) bound CD1d, another antigen found on the surface of several cancer types.More

HELPING PATIENTS ON THEIR JOURNEY TO BETTER HEALTH

Little Green Pharma (ASX:LGP) to benefit as Denmark commits to cannabis pilot program.

Latest Threads

Tag

Subject

ALA

Ann: Proposed issue of securities - ALA

01/08/25

216

01/08/25

Last post

ASX News

216

ALA

Ann: Investor Presentation

31/07/25

822

31/07/25

Last post Uttsy

822

ALA

Check out Mink Therapeutics

31/07/25

7.6K

31/07/25

Last post CBD

7.6K

ALA

Ann: Quarterly Activities/Appendix 4C Cash Flow Report

28/07/25

337

28/07/25

Last post

ASX News

337

ALA

Ann: Notification regarding unquoted securities - ALA

16/07/25

404

16/07/25

Last post

ASX News

404

ALA

ALA Investor Updates

15/07/25

17K

15/07/25

Last post abitlikeme

17K

ALA

Ann: Investor Presentation

15/07/25

5.0K

15/07/25

Last post Ozibobby

5.0K

ALA

Ann: Retirement of Non-Executive Chairman

10/07/25

2.6K

10/07/25

Last post Bluebush

2.6K

See All Discussions

Timeline

Proposed issue of securities - ALA
01 Aug 08:21	Share

Investor Presentation
28 Jul 10:36	Share

Quarterly Activities/Appendix 4C Cash Flow Report
28 Jul 10:29	Share

Notification regarding unquoted securities - ALA
16 Jul 08:54	Share

Notification of cessation of securities - ALA
07 Jul 08:58	Share

Investor Presentation
02 Jul 09:12	Share

Final Director's Interest Notice
01 Jul 11:11	Share

Notice Under Section 708A
30 Jun 12:01	Share

Retirement of Non-Executive Chairman
30 Jun 10:01	Share

Application for quotation of securities - ALA
27 Jun 11:27	Share

Notice Under Section 708A
24 Jun 09:19	Share

Application for quotation of securities - ALA
23 Jun 09:34	Share

Notice Under Section 708A
17 Jun 11:11	Share

Notification of cessation of securities - ALA
17 Jun 11:05	Share

Notification of cessation of securities - ALA
17 Jun 11:04	Share

Notification of cessation of securities - ALA
17 Jun 11:04	Share

Application for quotation of securities - ALA
17 Jun 11:03	Share

Application for quotation of securities - ALA
17 Jun 11:03	Share

Application for quotation of securities - ALA
17 Jun 11:02	Share

Results of Extraordinary General Meeting
08 May 14:12	Share

ALA exclusive iNKT technology option with Baylor
05 May 11:06	Share

Investor webinar presentation
29 Apr 11:03	Share

Notification regarding unquoted securities - ALA
24 Apr 14:24	Share

Quarterly Update Webinar
16 Apr 08:21	Share

Quarterly Activities/Appendix 4C Cash Flow Report
16 Apr 08:21	Share

Notice of Extraordinary General Meeting/Proxy Form
10 Apr 10:29	Share

Cancel - Proposed issue of securities - ALA
01 Apr 10:32	Share

Cancel - Proposed issue of securities - ALA
01 Apr 10:27	Share

Notification of cessation of securities - ALA
27 Mar 09:10	Share

Quotation of Options
26 Mar 10:13	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 10.5¢		Change 0.007(7.14%)		Mkt cap ! $124.7M

Open	High	Low	Value	Volume
9.9¢	10.5¢	9.8¢	$42.15K	421.5K

Buyers (Bids)

No.	Vol.	Price($)
2	169998	10.0¢

Sellers (Offers)

Price($)	Vol.	No.
10.5¢	287487	3

View Market Depth

No.	Vol.	Price($)
2	169998	0.100
2	108515	0.099
6	179835	0.098
4	177782	0.097
2	105001	0.096

Price($)	Vol.	No.
0.105	287487	3
0.110	435258	4
0.115	86947	1
0.120	235608	8
0.125	435476	4

Last trade - 16.10pm 01/08/2025 (20 minute delay)

ALA (ASX) Chart

AROVELLA THERAPEUTICS LIMITED

Latest Threads

Redcastle Resources Delivers Positive Scoping Study for Queen Alexandra

Timeline

Featured News

Latest Videos

Arovella Therapeutics licenses novel solid tumour targeting tech

12 Oct 2023 11:55 (AEDT)

Latest Articles

Arovella snaffles R&D rebate worth $3M for cancer cell therapy research

Arovella Therapeutics Ltd has received $3M from the Federal government for its research, and is anticipating $0.3M more in the month to come

Arovella Therapeutics (ASX:ALA) "thrilled" with $2.2m oversubscribed SPP

Arovella Therapeutics (ASX:ALA) has completed an oversubscribed share purchase plan, raising $2.2 million.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News